Viewing Study NCT03147612

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:17 PM
Ignite Modification Date: 2025-12-26 @ 10:17 PM
Study NCT ID: NCT03147612
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-13
First Post: 2017-05-05
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive View
None Acute Lymphoblastic Leukemia View
None Acute Myeloid Leukemia With BCR-ABL1 View
None Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive View
None Recurrent Acute Lymphoblastic Leukemia View
None Refractory Acute Lymphoblastic Leukemia View
Keywords: